Greenhaven Associates reported 26 stock positions (25 companies; some appear in two share classes) worth $8.0B in its 2026 Q3 Form 13F, for the quarter ended Sep 30, 2026, filed Oct 26, 2026. Its largest position is LENNAR CORP /NEW/ (LEN), at 13.38% of the reported portfolio value. Its biggest move versus the previous quarter was in JPMORGAN CHASE & CO (JPM), where it cut the position by 60.0%.
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| LEN | LENNAR CORP /NEW/ | 13.38% | 13,055,103 | ADDED (+15.4%) |
| BDX | BECTON DICKINSON & CO | 13.28% | 5,904,730 | ADDED (+3.9%) |
| GM | General Motors Co | 12.48% | 12,906,773 | ADDED (+0.3%) |
| TOL | Toll Brothers, Inc. | 9.50% | 5,614,009 | TRIMMED (-0.3%) |
| PHM | PULTEGROUP INC/MI/ | 7.86% | 5,394,549 | TRIMMED (-1.1%) |
| ICLR | ICON PLC | 6.55% | 3,069,015 | TRIMMED (-1.0%) |
| DHI | HORTON D R INC /DE/ | 6.44% | 3,753,844 | ADDED (+7.1%) |
| AVTR | Avantor, Inc. | 4.60% | 24,359,610 | TRIMMED (-1.1%) |
| ARW | ARROW ELECTRONICS, INC. | 4.24% | 1,486,774 | TRIMMED (-15.7%) |
| OSK | OSHKOSH CORP | 4.09% | 2,527,880 | TRIMMED (-1.2%) |
| AVT | AVNET INC | 4.02% | 3,205,515 | TRIMMED (-15.0%) |
| BAX | BAXTER INTERNATIONAL INC | 3.74% | 12,396,504 | TRIMMED (-13.2%) |
| SLB | SLB LIMITED/NV | 2.30% | 3,750,244 | TRIMMED (-1.4%) |
| IQV | IQVIA HOLDINGS INC. | 1.84% | 544,925 | TRIMMED (-29.1%) |
| LEA | LEAR CORP | 1.24% | 834,527 | TRIMMED (-42.7%) |
| NOV | NOV Inc. | 1.24% | 5,281,619 | TRIMMED (-6.0%) |
| MTH | Meritage Homes CORP | 1.08% | 1,367,579 | ADDED (+5.4%) |
| DNOW | DNOW Inc. | 0.85% | 4,377,190 | ADDED (+0.8%) |
| LEN.B | LENNAR CORP /NEW/ | 0.37% | 365,959 | ADDED (+0.5%) |
| A | AGILENT TECHNOLOGIES, INC. | 0.02% | 10,700 | HELD |
| CRH | CRH PUBLIC LTD CO | 0.02% | 17,500 | HELD |
| SCHW | SCHWAB CHARLES CORP | 0.01% | 10,500 | TRIMMED (-16.0%) |
| UNP | UNION PACIFIC CORP | 0.01% | 2,032 | HELD |
| BBWI | <0.01% | 10,000 | NEW | |
| G | Genpact LTD | <0.01% | 10,000 | HELD |
| JPM | JPMORGAN CHASE & CO | <0.01% | 1,000 | TRIMMED (-60.0%) |
The weights above sum to 99.2% of the fund’s reported 13F value. Only positions matched to a U.S.-listed ticker are listed; the remainder sits in unmatched or non-equity positions in the filing.
This 1 row completes the fund's 27-row 2026 Q3 filing (26 ticker rows above + 1 row here). Each issuer name is shown exactly as filed, with no stock link, because no U.S. ticker is confirmed for these securities. Together the 27 rows sum to 100.0% of the reported 13F value (rounding). The weights note above applies to the ticker table only.
| Issuer (as filed) | Weight | Shares | Change |
|---|---|---|---|
| Vanguard 0-3M T-Bill ETF (VBIL) | 0.82% | 858,916 | HELD |
Exited this quarter: ACN, EPAM, STLA, TEX, TMHC.
Source: SEC Form 13F filing for the quarter ended Sep 30, 2026, filed Oct 26, 2026. CIK 0000846222. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only and report holdings as of quarter-end; each filing is due within 45 days after quarter-end, so the filing lag above is the gap between quarter-end and this filing’s date, and it varies by when the manager actually filed.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Hypothetical 13F-clone performance — not the fund’s actual returns. The clone holds the long U.S. equity positions disclosed in this manager’s Form 13F filings at their reported weights, rebalanced on filing dates, on dividend-adjusted prices. Full series and the filing-by-filing evidence dossier: 13F-clone profile.
A snapshot at quarter-end, not today’s portfolio: 13F filings arrive up to 45 days late, cover long positions only, and omit cash, shorts, and derivatives. Copying this list also means copying its timing, prices, and position sizes.
Read the original filings at SEC EDGAR.
Not investment advice. Filings are delayed and incomplete.
How we measure: Methodology · Track Record · Q3 2026 13F tracker.
See the same rule applied to every tracked fund, including this one: Follow a Fund — each quarter’s top 5 new and increased positions, bought at the close on the first trading day after the 13F deadline and held for a quarter, scored against SPY.
Compare overlap → Compare your own book against this fund and the other tracked funds.
Oakmark Funds · Track Record: how the signals scored · Compare overlap
One email a week: the week’s new filings and research. Subscribe free
← Giverny Capital · Greenlea Lane Capital →
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.